SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 62 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $207,545 | -21.0% | 297,129 | +1.8% | 0.00% | 0.0% |
| Q4 2022 | $262,751 | +317.1% | 291,946 | +2672.8% | 0.00% | – |
| Q3 2022 | $63,000 | +10.5% | 10,529 | -23.0% | 0.00% | – |
| Q2 2022 | $57,000 | -70.6% | 13,669 | -73.2% | 0.00% | -100.0% |
| Q1 2022 | $194,000 | -56.4% | 51,074 | -48.4% | 0.00% | 0.0% |
| Q4 2021 | $445,000 | -28.7% | 98,947 | -26.2% | 0.00% | 0.0% |
| Q3 2021 | $624,000 | -70.6% | 134,011 | -55.4% | 0.00% | -80.0% |
| Q2 2021 | $2,120,000 | +73.9% | 300,699 | +45.8% | 0.01% | +66.7% |
| Q1 2021 | $1,219,000 | +271.6% | 206,240 | +190.0% | 0.00% | +200.0% |
| Q4 2020 | $328,000 | -67.2% | 71,110 | -72.4% | 0.00% | -75.0% |
| Q3 2020 | $1,001,000 | – | 257,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |